EP3509660A1 - Unité de filtration comprenant un bord périphérique courbe - Google Patents
Unité de filtration comprenant un bord périphérique courbeInfo
- Publication number
- EP3509660A1 EP3509660A1 EP17768497.4A EP17768497A EP3509660A1 EP 3509660 A1 EP3509660 A1 EP 3509660A1 EP 17768497 A EP17768497 A EP 17768497A EP 3509660 A1 EP3509660 A1 EP 3509660A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- filtration unit
- housing
- unit according
- filtration
- fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
- A61M1/0218—Multiple bag systems for separating or storing blood components with filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0281—Apparatus for treatment of blood or blood constituents prior to transfusion, e.g. washing, filtering or thawing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3627—Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
- A61M1/3633—Blood component filters, e.g. leukocyte filters
- A61M1/3635—Constructional details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0439—White blood cells; Leucocytes
Definitions
- Filtration unit comprising a curved peripheral edge
- the invention relates to a filtration unit for a biological fluid such as blood or a blood component and a bag system comprising such a filtration unit.
- the invention applies to the field of filtration of biological fluids and in particular the filtration of blood or blood components.
- it is conventional to treat the blood to remove undesirable substances such as leukocytes, pathogens, certain proteins - for example the prion - and / or substances used in inactivation processes, reduction and / or elimination of pathogens.
- undesirable substances such as leukocytes, pathogens, certain proteins - for example the prion - and / or substances used in inactivation processes, reduction and / or elimination of pathogens.
- a filtration medium capable of removing undesirable substances from the fluid is enclosed in these filtration units.
- filtration units are generally integrated in pouch systems for treating blood and blood components in a closed circuit.
- the rigid filtration units comprise casings with edges forming substantially straight angles and furthermore have fluid inlet and / or outlet orifices projecting from the casing, forming sharp edges. With the pressure generated by centrifugation, these angular parts can perforate the pockets.
- a method for manufacturing a rigid filtration unit comprising the alignment of a filtration medium between two housing elements and the injection molding of an overmolded strip. rigid thermoplastic around the two housing members so as to form a hermetic seal at the end of the filtration medium.
- the filtration unit obtained comprises protrusions and angular parts unsuitable for centrifugation with flexible bags.
- the invention provides a substantially rigid type filtration unit that can be centrifuged in a centrifuge cup with soft pouches without damaging them.
- the invention proposes a filtration unit intended for the filtration of a fluid, comprising a housing formed of a first housing element and a second housing element, between which a filtration medium is arranged. so as to define an inlet compartment for the fluid to be filtered and an outlet compartment for the filtered fluid, said housing having an inlet duct opening into the inlet compartment and an outlet duct opening into the outlet compartment each of said housing members comprising a bottom extending in a median plane surrounded by a periphery, said housing members being sealingly joined together at their periphery, the housing having a peripheral edge having an outer profile curve that extends between the median planes of funds.
- the invention relates to a bag system for filtering a fluid, comprising:
- a bag for collecting the filtrate said collection bag being connected, via a first tube, to the outlet duct of the filtration unit.
- FIG. 1 represents a schematic perspective view of the filtration unit according to one embodiment of the invention.
- Figures 2 to 4 show schematic views of two different profiles of the filtration unit of Figure 1.
- FIG. 5 represents a schematic view from above of the filtration unit of FIG. 1.
- FIG. 6 represents a schematic sectional view of the filtration unit of FIG. 1.
- FIG. 7a and 7b show a partial schematic sectional view of a filtration unit according to two other embodiments.
- FIG. 8 represents a schematic exploded and profile view of the first and second housing elements and the filtration medium of the filtration unit of FIG. 1.
- FIG. 9 represents a schematic view of a bag system comprising the filtration unit of FIG. 1.
- the invention relates to a filtration unit for the filtration of a fluid, in particular blood or a blood component such as a plasma including a platelet-rich plasma and a platelet-poor plasma, a concentrate of red blood cells. or a platelet concentrate.
- a fluid in particular blood or a blood component
- a plasma including a platelet-rich plasma and a platelet-poor plasma
- a concentrate of red blood cells or a platelet concentrate.
- the filtration unit is intended to remove target components of the fluid, including leukocytes, prion proteins or pathogen inactivation substances such as methylene blue.
- the filtration unit 1 comprises a rigid housing formed of a first housing element 2 and a second housing element 3 between which a filtration medium 4 is arranged so as to define an inlet compartment 5 for the fluid to be filtered and an outlet compartment 6 for the filtered fluid.
- the housing elements are in particular made of a thermoplastic polymer material such as polycarbonate, polyvinyl chloride, polypropylene or acrylonitrile-butadiene-styrene.
- the inlet compartment 5 is limited by the first housing element 2 and the filtration medium 4.
- the outlet compartment 6 is limited by the second housing element 3 and the filtration medium 4.
- This filtration unit 1 is intended to filter a biological fluid that is, for example a biological fluid such as blood or a blood component.
- the filtration medium 4 is capable of removing leukocytes from blood or a blood component.
- the filtration medium comprises in particular one or more layers of a woven or non-woven material.
- the filtration medium comprises an assembly of several layers of nonwoven.
- the material (s) forming the layer (s) of the leukocyte removal medium are chosen from the group comprising polymers or copolymers based on polypropylene, polyester, polyamide, high or low density polyethylene. , polyurethane, polyvinylidene fluoride, polyvinylpyrrolidone and their derivatives.
- the material is polypropylene, polyethylene terephthalate or polybutylene terephthalate.
- the housing comprises an inlet duct 7 opening into the inlet compartment 5 and an outlet duct 8 opening into the outlet compartment 6.
- the inlet duct 7 and the outlet duct 8 are arranged parallel to said filtration medium 4.
- the inlet and outlet ducts 7, 8 are in particular hollow and rigid tubular ducts. These ducts are able to receive a flexible tubing to be able to integrate the filtration unit in a bag system such as that shown in Figure 8.
- the first housing element 2 comprises the inlet duct 7 for the fluid to be filtered and the second housing element 3 comprises the outlet duct 8 for the filtrate.
- each of the first and second housing elements 2,3 comprises a bottom 9,10 surrounded by a peripheral wall 25, 26, the bottom of at least one of said housing elements comprising a main portion 1 1, 12 and at least one dome portion 13,14 which is delimited by a periphery having an inner wall 15,16 extending from said periphery to an apex 17,18 and an outer wall 19,20 extending from said apex 17,18 towards said periphery.
- each of the housing elements extends in a median plane P5, P6 being surrounded by a peripheral wall 25, 26.
- the main portion 1 1, 12 of the bottom of the housing elements 2, 3 is in particular substantially plane and defines a base plane.
- the dome portion 13, 14 of the bottom of the housing members 2,3 does not advantageously comprise any angular portion, so that the risk of perforating adjacent pockets during centrifugation is reduced.
- the internal and external walls 19 of the dome portion 13 of one of the housing elements 2 respectively extend in a median plane P1, P2 forming between them an angle a1 strictly greater than 90. °, particularly between 100 ° and 130 °.
- the inner and outer walls 16 of the dome portion 14 of the other housing element 3 respectively extend in a median plane P3, P4 forming between them an angle a2 strictly greater than 90 °, particularly between 100 ° and 130 °.
- median plane of a wall is meant the plane located in the middle of said wall.
- the apex 17,18 of the dome portion 13,14 has a curved outer profile which extends between said median planes P1, P2 and P3, P4 at the junction between the internal walls 15,16 and outer 19 20.
- the outer contour of the dome portion 13,14 thus does not have a straight or flat portion.
- the curved outer profile has, seen in profile, a radius of curvature strictly greater than the height of the dome portion taken from the base plane P5, P6 of the main portion 1 1, 12 of the bottom of the housing element 2,3.
- the median plane of the inner wall P1, P3 of the dome portion 13, 14 forms an angle ⁇ 3, ⁇ 4 of between 120 ° and 150 ° with the basic plane P5, P6 of the main portion 1 1, 12 from the bottom.
- the median plane P2, P4 of the outer wall 19,20 of the dome portion 13,14 forms an angle ⁇ 5, ⁇ 6 of between 120 ° and 150 ° with a base plane P5, P6 of the main portion 11, 12 from the bottom 9,10.
- the dome portion 13, 14 is relatively low so that the dead volume of the housing of the filtration unit 1 is reduced.
- the outer wall 19,20 extends from the apex 17, 18 towards a portion of the periphery which is adjacent to the peripheral wall 25, 26 of the bottom 9, 10.
- the inner wall 15,16 extends towards the apex 17,18 from a substantially U-shaped portion of the periphery. Even more particularly, the ends of the branches of the U are adjacent to the peripheral wall 25, 26 of the bottom 9,10.
- the dome portion 13, 14 of the housing element 2, 3 is located in the vicinity of the peripheral wall 25, 26 of the bottom 9, 10 of the housing element 2, 3.
- the bottom 9,10 has a dimension that extends along the main portion 1 1, 12 and the domed portion 13,14, the inner wall 15,16 extending along said dimension over a distance of between 20% and 40% of said dimension.
- At least one of the inlet and outlet ducts 7 opens out through the outer wall 19, 20 of the dome portion 13, 14 of a housing element 2, 3.
- an outer end of an inlet conduit 7 and outlet 8 opens into the outer wall 19,20 adjacent to the peripheral wall 25, 26 of the bottom 9,10 of the housing element 2,3.
- the outer wall 19,20 has an orifice in which at least one outer end 21, 22 of an inlet duct 7 and outlet 8 is inscribed.
- the dome portion 13,14 then completely covers the inlet duct 7 or outlet 8, so that no brittle projecting element extends from the dome portion 13,14.
- the raised portions of the housing thus have a curved shape so that, regardless of the position of the housing in the centrifuge bucket, the risk of rupture of the inlet and outlet ducts 7,8 and the risk of damaging the nearby pockets are reduced and even eliminated.
- the outer end 21, 22 of the inlet duct and / or outlet 7.8 is not straight, that is to say that it is not perpendicular to the axis longitudinal of the inlet duct and / or outlet 7.8.
- the outer end of the inlet and / or outlet duct 7, 8 has a bevel.
- the orifice is then substantially oval.
- At least one of the inlet and outlet ducts 7, 8 has at its internal end 23, 24 an opening having a section smaller than the section of the opening of said duct. 7.8 at its outer end 21, 22 ( Figure 6).
- each of the housing elements 2,3 has a dome portion 13, the inlet duct 7 opening into the outer wall 19 of the dome portion 13 of said first housing element 2 and the outlet duct 8 opening into the outer wall 20 of the dome portion 14 of said second housing member 3.
- each of the first and second housing members 2,3 comprises a cavity formed of the bottom 9,10 and a peripheral side wall 25,26, the dome portion 13,14 being arranged on the outer surface of the bottom 9,10 of one of the first or second housing members 2,3.
- the housing members 2,3 are sealingly joined together at their periphery so as to form a fluid-tight housing.
- first and second housing members 2,3 are assembled together by high frequency, radio frequency or ultrasonic welding.
- the housing elements 2,3 are assembled by gluing.
- the housing elements 2,3 are fitted together by means of a form-fitting or snap-fitting connection.
- peripheral side wall 25 of the first housing element 2 and the peripheral side wall 26 of the second housing element 3 are brought into contact on their end surface by shape conjugation.
- the housing of the filtration unit 1 has a peripheral edge 27 having a curved outer profile that extends between the median planes P5, P6 of the bottoms 9,10 of the first and second housing members 2,3.
- This peripheral edge 27 with a curved outer profile contributes to reducing the risk of damage to the flexible bags when the filtration unit and the flexible bags are centrifuged in the same cup.
- the profile of the peripheral edge 27 has substantially no planar portion.
- the curved outer profile of the peripheral edge 27 has a radius of curvature that is greater than half the distance between the two median planes P5, P6.
- the radius of curvature is the radius of the circle tangent to the curved outer profile of the peripheral edge seen in cross section.
- the filter unit comprises an element 28 which is attached to the assembly of the peripheries of the housing elements 2,3, the peripheral edge 27 having a curved outer profile being formed on said insert 28.
- the insert 28 is arranged to seal the assembly of the peripheries of the housing members 2,3.
- the insert 28 is associated around the peripheries of the housing elements 2, 3.
- the element 28 is overmolded onto the assembly of the peripheries of the housing elements 2, 3.
- Overmolding consists in placing, in the cavity cavity of an injection mold, the housing of the filtration unit 1, and injecting the insert element 28. The filling of the cavity allows to over-mold the housing with the insert 28.
- the insert 28 adheres to the housing elements 2,3 by physicochemical connection, the housing thus not allowing the fluid to pass to the outside .
- the assembly of the housing is performed automatically at the time of overmolding.
- the element 28 is attached between the two housing members 2,3, without extending on the outer surface of the housing members 2,3.
- the two peripheral side walls 25,26 forming part of the peripheral edge 27 of the housing have a curved outer surface.
- the insert element 28 has a U-shaped profile, each branch extending substantially in a median plane P5, P6, respectively, so as to be arranged in the extension of a bottom 9, 10.
- the insert 28 extends in part over the first and second housing members 2,3.
- the insert 28 is advantageously made of an elastomeric thermoplastic material, so as to protect the filter unit from possible shocks and to avoid damaging the bag system during centrifugation.
- the insert 28 thus has not only an assembly function but also a protective cushion.
- the peripheries of the housing members 2,3 have a complementary geometry which is arranged to form a peripheral recess 29 at their interface, the insert 28 being disposed in said recess.
- the geometry and dimensions of the peripheral recess 29 are configured so that, during overmoulding, the insert 28 and / or the housing elements 2, 3 do not melt at the level of the filtration medium 4.
- added element 28 is made of a material identical to or different from that of the housing elements 2,3.
- the insert 28 is made of a thermoplastic polymer material of the same family as the material used for the housing elements 2.3.
- the insert 28 is made of a thermoplastic material, in particular a thermoplastic elastomer material.
- the insert 28 is made of a thermoplastic polymer material such as polycarbonate, polyvinyl chloride, polypropylene or acrylonitrile-butadiene-styrene.
- the insert 28 is made of a thermoplastic elastomer material, in particular based on polyurethane or based on styrenic polymers.
- thermoplastic elastomer material in particular based on polyurethane or based on styrenic polymers.
- overmolding material are Dryflex products from Hexpol or Hytrel from DuPont.
- the insert 28 has a hardness of between 50 and 100 Shore A, less than the hardness of at least one of the housing elements 2,3.
- the sealing element has a hardness of about 70 shore A.
- the peripheries of the housing elements 2, 3 have a complementary geometry which is arranged to form the peripheral edge 27 having a curved outer profile.
- each of the housing elements 2, 3 comprises an inner conjugation element 49, 50 substantially parallel to the side wall 25, 26.
- the two inner elements of 49.50 conjugation of each of the housing members 2,3 cooperate by shape conjugation, so that once the housing members 2,3 are assembled together, a hollow portion 51 is formed between the side walls 25,26 and the inner mating elements 49 50.
- the housing of the filtration unit 1 further comprises one or more protective elements reported by overmolding an elastomeric thermoplastic material configured to protect the housing shocks and / or avoid damage to the flexible bags.
- the filtration medium 4 is disposed between the two housing members 2, 3 and is held tightly there.
- each of the housing elements 2,3 comprises an inner projection 30, 31 arranged to compress the filtration medium 4 along its periphery.
- the inner projections 30, 31 are arranged to compress the filtration medium 4 along its periphery so as to create an internal fluid-tight zone.
- each of the housing elements 2,3 further comprises an outer projection 32,33 arranged to compress the filtration medium 4 along its periphery.
- the outer projections 32, 33 are arranged to compress the filtration medium 4 so as to create an external fluid sealing zone.
- the adjective "outside” is to be understood as opposed to the adjective “inside”.
- “Inner” means means means located in an area of the filtration unit closer to the center of the filtration unit than a so-called “outside” means.
- the inner 30,31 and outer 32,33 projections are formed of continuous ribs. These ribs have a substantially triangular shaped section with a rounded apex.
- these comprise in particular a first and a second clamping portion 34, 35, respectively arranged to keep the filtering medium tightly in the housing along its periphery.
- the clamping portions 34, 35 of the housing elements compress the filtration medium 4 so as to reduce the thickness, without being able to provide fluid tightness.
- the clamping portions 34, 35 are arranged on the bottom 9, 10 of the cavities of the casing elements 2, 3.
- the first and second housing members 2,3 respectively comprise a first and a second cavity each provided with an outwardly directed peripheral platform forming the first and second clamping portion 34,35 respectively, arranged to hold tightly in the housing the filtration medium 4 along its periphery.
- the filtration medium 4 is kept tight between the first and the second platform, which compresses the filtration medium along its periphery.
- the inner 30,31 and 32,33 outer projections are then located on these platforms, especially at their inner end.
- the first housing element 2 and the second housing element 3 each comprise on their inner surface, in particular on the inner surface of the bottom 9, 10, a flow deflector formed of a plurality of reliefs 36.37.
- each of the housing elements 2, 3 is provided on the inner surface of the bottom 9, 10 with a plurality of linear reliefs 36, 37 directed obliquely towards the inlet and outlet ducts.
- the baffles help to distribute the flow of fluid to be filtered over the entire surface of the filtration medium.
- the baffles help direct the filtered fluid to the outlet duct of the filtration unit.
- the invention relates to a bag system 38 for filtering a fluid, comprising:
- the bag system 38 further comprises a bag 41 intended to contain the fluid to be filtered, said bag 41 for the fluid to be filtered being connected via a second tubing 42, to the conduit. inlet 7 of the filtration unit 1.
- This pocket 41 for the fluid to be filtered is either connected to the filtration unit 1 by way of the second pipe 42 or is connected by the user using a perforator-type connector provided with the free end of the second tubing (not shown).
- Figure 9 shows more particularly an example of a bag system 38 used to separate plasma and packed red blood cells from a whole blood donation and to leukocyte red blood cell concentrate.
- the bag system 38 includes a needle 43 for taking blood from a donor, a primary bag 44 for collecting whole blood, a satellite bag 45 for receiving the plasma in fluid communication with the primary bag, a satellite bag 41 intended to receive the red blood cell concentrate in fluid communication with the primary bag, a filtration unit 1 as described above for filtering the leucocytes of the red blood cell concentrate in fluid communication with the satellite bag to receive the red blood cell concentrate, and a filtrate collection bag 39 in fluid communication with the filtration unit 1.
- the pockets and the filtration unit 1 are interconnected by means of flexible tubing 40,42,46,47,48 and sterilizable.
- the primary bag 44 contains a CPD type anticoagulant and the filtrate collection bag 39 contains an additive solution for the preservation of SAGM (Saline Adenine Glucose Mannitol) red blood cells.
- SAGM Seline Adenine Glucose Mannitol
- the bag system 38 containing the whole blood mixed with the anticoagulant solution in the primary bag 44 is placed in a centrifugation cup to be centrifuged so as to separate the blood into three layers: a supernatant comprising the plasma, a diaper intermediate buffy coat comprising a mixture of platelets, plasma and red blood cells and a pellet comprising the concentrate of red blood cells.
- a supernatant comprising the plasma
- a diaper intermediate buffy coat comprising a mixture of platelets
- plasma and red blood cells a pellet comprising the concentrate of red blood cells.
- the additive solution is then sent from the filtrate collection bag 39 to the satellite bag 41 for receiving the red blood cells.
- the red blood cell concentrate, mixed with the additive solution, is finally gravity filtered through the filtration unit 1 and the filtrate is received in the pocket for collecting the filtrate 39.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- External Artificial Organs (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1658379A FR3055557B1 (fr) | 2016-09-08 | 2016-09-08 | Unite de filtration comprenant un bord peripherique courbe |
| PCT/FR2017/052353 WO2018046843A1 (fr) | 2016-09-08 | 2017-09-05 | Unité de filtration comprenant un bord périphérique courbe |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EP3509660A1 true EP3509660A1 (fr) | 2019-07-17 |
| EP3509660C0 EP3509660C0 (fr) | 2024-12-11 |
| EP3509660B1 EP3509660B1 (fr) | 2024-12-11 |
Family
ID=57137188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP17768497.4A Active EP3509660B1 (fr) | 2016-09-08 | 2017-09-05 | Unité de filtration comprenant un bord périphérique courbe |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3509660B1 (fr) |
| FR (1) | FR3055557B1 (fr) |
| WO (1) | WO2018046843A1 (fr) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12379916B2 (en) | 2022-03-10 | 2025-08-05 | Terumo Bct, Inc. | Communications and operation control of apheresis systems |
| US12458740B2 (en) | 2022-03-10 | 2025-11-04 | Terumo Bct, Inc. | Modular serviceability sleds and interconnections |
| US12478551B2 (en) | 2022-03-10 | 2025-11-25 | Terumo Bct, Inc. | Collection bottle with integrated cap, handle, and shield features |
| US12599710B2 (en) | 2022-03-10 | 2026-04-14 | Terumo Bct, Inc. | Methods and interfaces for providing donation process feedback |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5100564A (en) | 1990-11-06 | 1992-03-31 | Pall Corporation | Blood collection and processing system |
| FR2677883B1 (fr) | 1991-06-24 | 1997-07-18 | Maco Pharma Sa | Poche filtrante destinee a permettre la filtration sterile du sang et ensemble de poches de prelevement de sang. |
| US5547591A (en) | 1993-06-01 | 1996-08-20 | Asahi Medical Co., Ltd. | Method for separating a blood material into blood components by centrifugation, and centrifugal apparatus |
| US5556541A (en) | 1994-04-26 | 1996-09-17 | Filtertek, Inc. | Process for making hermetically sealed filter units and filters made thereby |
| JP4404445B2 (ja) * | 2000-05-17 | 2010-01-27 | テルモ株式会社 | 血液フィルターおよび血液フィルターの製造方法 |
| EA016521B1 (ru) | 2007-02-22 | 2012-05-30 | Хемерус Медикал, Ллк | Аппарат высокой производительности для фильтрации биологических жидкостей |
| EP2659920B1 (fr) * | 2010-12-27 | 2017-05-31 | Asahi Kasei Medical Co., Ltd. | Filtre pour traitement de sang, et procédé d'amorçage pour filtre de traitement de sang |
| JP5922777B2 (ja) * | 2012-07-25 | 2016-05-24 | 旭化成メディカル株式会社 | 血液処理フィルター、血液回路、及び血液処理方法 |
-
2016
- 2016-09-08 FR FR1658379A patent/FR3055557B1/fr active Active
-
2017
- 2017-09-05 WO PCT/FR2017/052353 patent/WO2018046843A1/fr not_active Ceased
- 2017-09-05 EP EP17768497.4A patent/EP3509660B1/fr active Active
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12379916B2 (en) | 2022-03-10 | 2025-08-05 | Terumo Bct, Inc. | Communications and operation control of apheresis systems |
| US12458740B2 (en) | 2022-03-10 | 2025-11-04 | Terumo Bct, Inc. | Modular serviceability sleds and interconnections |
| US12478551B2 (en) | 2022-03-10 | 2025-11-25 | Terumo Bct, Inc. | Collection bottle with integrated cap, handle, and shield features |
| US12599710B2 (en) | 2022-03-10 | 2026-04-14 | Terumo Bct, Inc. | Methods and interfaces for providing donation process feedback |
Also Published As
| Publication number | Publication date |
|---|---|
| FR3055557A1 (fr) | 2018-03-09 |
| EP3509660C0 (fr) | 2024-12-11 |
| EP3509660B1 (fr) | 2024-12-11 |
| WO2018046843A1 (fr) | 2018-03-15 |
| FR3055557B1 (fr) | 2018-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3509659B1 (fr) | Unité de filtration comprenant des portions en dôme | |
| EP1382361B1 (fr) | Unité de déleucocytation sélective d'un fluide contenant des plaquettes sanguines | |
| EP2326363B1 (fr) | Unité de filtration d'un fluide munie d'une interruption de joint | |
| CA2682269C (fr) | Unite de filtration d'un fluide biologique munie d'un element d'entree et/ou de sortie decale | |
| EP3509660B1 (fr) | Unité de filtration comprenant un bord périphérique courbe | |
| WO2017085372A1 (fr) | Unité de filtration rigide comprenant des saillies de compression | |
| EP0953361B1 (fr) | Poche et ensemble de poches de filtration | |
| EP0770402B1 (fr) | Poche souple de filtration pour sang | |
| FR2825617A1 (fr) | Poche pourvue de moyens d'association temporaire d'un filtre | |
| FR3061436A1 (fr) | Etui de protection pour composants d'un systeme a poches | |
| WO2008043190A1 (fr) | Ensemble jetable pour la separation de sang ou le lavage de composant du sang | |
| EP2889048B1 (fr) | Procédé d'extraction de composants sanguins à l'aide d'une poche filtrante | |
| EP1106192A1 (fr) | Unité de filtration d'un fluide | |
| EP2889049B1 (fr) | Réceptacle destiné à recevoir un système à poches pour le traitement du sang | |
| FR3015902A1 (fr) | Procede pour extraire au moins un premier et un deuxieme composant sanguin contenus dans une poche primaire d'un systeme a poches | |
| FR2932989A1 (fr) | Unite de filtration pourvue d'un compartiment annexe | |
| FR2928838A1 (fr) | Dispositif de raccordement/protection de capteur, en particulier pour des lignes biomedicales d'hemodialyse | |
| EP4292621B1 (fr) | Dispositif de maintien pour unite de filtration d'un fluide biologique | |
| EP0098228B1 (fr) | Appareil à membranes semi-perméables, utilisable plus particulièrement en plasmaphérèse | |
| FR2514647A1 (fr) | Hemodialyseur a fibres creuses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20190408 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20220223 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20240516 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602017086706 Country of ref document: DE |
|
| U01 | Request for unitary effect filed |
Effective date: 20250109 |
|
| U07 | Unitary effect registered |
Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT RO SE SI Effective date: 20250213 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20241211 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20241211 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250311 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250312 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250311 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20241211 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20241211 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20250411 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20241211 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20241211 |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20250912 |